Info@ThinkPinkRocks.com

Intravenous PEG-asparaginase use recommended in paediatric ALL

Phase III trial results support the use of intravenously administered PEGylated Escherichia coli asparaginase as the preparation of choice in children and adolescents with acute lymphoblastic leukaemia.

Read this article:
Intravenous PEG-asparaginase use recommended in paediatric ALL

Share

Leave a Reply